세계의 결핵 진단 시장 리포트(2023년)

“Tuberculosis Diagnostics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tuberculosis diagnostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Radiographic Test; Laboratory Test; Nucleic Acid Testing; Cytokine Detection Test; Drug Resistance Test; Other Diagnostic Test Types

• 2) By Test: Nucleic Acid Testing (NAT); Skin Test / Mantoux Test (TST); Blood Test / Serology Test; SMEAR Microscopy; Cultured-Based Tests; Radiography Tests; Other Test

• 3) By Disease Stage: Latent Tuberculosis; Active Tuberculosis

• 4) By End User: Hospitals and Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics and Research Facilities

• Companies Mentioned: Abbott Laboratories; Becton Dickinson and Company; BioMerieux SA; Cepheid; F Hoffmann-La Roche AG

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the tuberculosis diagnostics market are: Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Cepheid, F Hoffmann-La Roche AG, Hologic Inc., AdvaCare Pharma, Thermo Fisher Scientific Inc., Siemens AG, Akonni Biosystems Inc., Alere Inc., Par Pharmaceutical, Lionex GmbH, Creative Diagnostics, bioMerieux Clinical Diagnostics, Epistem Limited, and Gen-Probe.

The global tuberculosis diagnostics market is expected to grow from $1.99 billion in 2022 to $2.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The tuberculosis diagnostics market is expected to reach $2.76 billion in 2027 at a CAGR of 6.6%.

The tuberculosis diagnostics market includes revenues earned by entities by providing services realted to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2022. The regions covered in the tuberculosis diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The various types of tuberculosis diagnostic markets include radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, and others. Radiographic tests are used to detect chest abnormalities in the case of tuberculosis symptoms. The radiographic test refers to the diagnosis of lesions that may develop anywhere in the lungs and vary in terms of cavitation, density, size, and shape. The tests include nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and others, used for disease stages such as latent tuberculosis and active tuberculosis. The end-users of tuberculosis diagnostics include hospitals and diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2022, in the weekly report of the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis infections in the United States increased by 9.4% in 2021, with a total of 7,860 TB cases were reported in 2021, an increase from 7,173 cases in 2020 but a decrease from 8,900 cases in 2019. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.

Technological innovations are the key trend gaining popularity in the tuberculosis diagnostics market. Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.

In March 2021, PerkinElmer, a US-based company engaged in diagnostics and scientific research, acquired Oxford Immunotec for $591 million. With this acquisition, PerkinElmer would expand its offering of infectious disease testing solutions, including tuberculosis detection, to serve clients worldwide. Oxford Immunotec is a UK-based company engaged in developing and commercializing proprietary assays for immunology and infectious disease.

The countries covered in the tuberculosis diagnostics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Tuberculosis Diagnostics Market
• 4.2. Ukraine-Russia War Impact On Tuberculosis Diagnostics Market
• 4.3. Impact Of High Inflation On Tuberculosis Diagnostics Market

5. Tuberculosis Diagnostics Market Size And Growth

• 5.1. Global Tuberculosis Diagnostics Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Tuberculosis Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Tuberculosis Diagnostics Market Segmentation

• 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Radiographic Test
• Laboratory Test
• Nucleic Acid Testing
• Cytokine Detection Test
• Drug Resistance Test
• Other Diagnostic Test Types
• 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Nucleic Acid Testing (NAT)
• Skin Test / Mantoux Test (TST)
• Blood Test / Serology Test
• SMEAR Microscopy
• Cultured-Based Tests
• Radiography Tests
• Other Tests
• 6.3. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Latent Tuberculosis
• Active Tuberculosis
• 6.4. Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals and Diagnostic Laboratories
• Physician's Office Laboratories
• Reference Laboratories
• Academics and Research Facilities

7. Tuberculosis Diagnostics Market Regional And Country Analysis

• 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

• 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Tuberculosis Diagnostics Market

• 9.1. China Tuberculosis Diagnostics Market Overview
• 9.2. China Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Tuberculosis Diagnostics Market

• 10.1. India Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Tuberculosis Diagnostics Market

• 11.1. Japan Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Tuberculosis Diagnostics Market

• 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

• 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

• 14.1. South Korea Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

• 15.1. Western Europe Tuberculosis Diagnostics Market Overview
• 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Tuberculosis Diagnostics Market

• 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Tuberculosis Diagnostics Market

• 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Tuberculosis Diagnostics Market

• 18.1. France Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Tuberculosis Diagnostics Market

• 19.1. Eastern Europe Tuberculosis Diagnostics Market Overview
• 19.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Tuberculosis Diagnostics Market

• 20.1. Russia Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Tuberculosis Diagnostics Market

• 21.1. North America Tuberculosis Diagnostics Market Overview
• 21.2. North America Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Tuberculosis Diagnostics Market

• 22.1. USA Tuberculosis Diagnostics Market Overview
• 22.2. USA Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Tuberculosis Diagnostics Market

• 23.1. South America Tuberculosis Diagnostics Market Overview
• 23.2. South America Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Tuberculosis Diagnostics Market

• 24.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Tuberculosis Diagnostics Market

• 25.1. Middle East Tuberculosis Diagnostics Market Overview
• 25.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Tuberculosis Diagnostics Market

• 26.1. Africa Tuberculosis Diagnostics Market Overview
• 26.2. Africa Tuberculosis Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

• 27.1. Tuberculosis Diagnostics Market Competitive Landscape
• 27.2. Tuberculosis Diagnostics Market Company Profiles
  • 27.2.1. Abbott Laboratories
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Becton Dickinson and Company
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. BioMerieux SA
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Cepheid
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. F Hoffmann-La Roche AG
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

29. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer